Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 20:22 UTC |
Fuchs Charles S.President, R&D
|
GrantStock option (right to buy) · Derivative | 1,300,000 | $0.00 Strike: $18.12 | $0.00 |
DisclosureSEC source: 0001193125-26-346924 · ownership.xml · derivative · entry 1 Fuchs Charles S. · CIK 0001719576 · President, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,300,000 Underlying: Common Stock · 1,300,000 shares Expires 2036-08-09 F1 · shares: The reported option award was granted in connection with the Reporting Person's commencement of employment. Of the total option award, 21,480 shares were granted under the Issuer's 2021 Incentive Award Plan, with a portion intended to qualify as an incentive stock option under Section 422 of the Internal Revenue Code to the extent permitted by law. The remaining 1,278,520 shares were granted as a nonqualified stock option under the Issuer's 2026 Employment Inducement Incentive Award Plan. F2 · derivative.exercise_date: The reported option award vests as follows: 25% of the shares subject to the option will vest on the first anniversary of the date of grant, and the remaining 75% of the shares will vest in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:07 UTC |
Start Valerie Denise HardingDirector
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288910 · ownership.xml · derivative · entry 1 Start Valerie Denise Harding · CIK 0001652037 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:06 UTC |
LIU JEAN IDirector
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288908 · ownership.xml · derivative · entry 1 LIU JEAN I · CIK 0001241357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:05 UTC |
Multani Pratik SDirector
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288906 · ownership.xml · derivative · entry 1 Multani Pratik S · CIK 0001586894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:05 UTC |
Casdin Alexander W.Director
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288905 · ownership.xml · derivative · entry 1 Casdin Alexander W. · CIK 0001455228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:03 UTC |
Hambleton JulieDirector
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288903 · ownership.xml · derivative · entry 1 Hambleton Julie · CIK 0001578771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 26, 2026 Filed Jun 29, 2026 23:03 UTC |
Bristol James ArthurDirector
|
GrantStock option (right to buy) · Derivative | 29,888 | $0.00 Strike: $16.01 | $0.00 |
DisclosureSEC source: 0001193125-26-288902 · ownership.xml · derivative · entry 1 Bristol James Arthur · CIK 0001715153 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,888 Underlying: Common Stock · 29,888 shares Expires 2036-06-26 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 26, 2027, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC |
Garner EbunChief Legal Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · derivative · entry 3 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 80,000 shares Expires 2034-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC |
Garner EbunChief Legal Officer
|
SaleCommon Stock | 80,000 | $16.40 | $1,312,000.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F2 · price: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.11 to $16.58. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 13:00 UTC |
Garner EbunChief Legal Officer
|
Exercise / conversionCommon Stock | 80,000 | $1.70 | $136,000.00 |
DisclosureSEC source: 0001193125-26-141395 · ownership.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 14:00 UTC |
Morris ShannonChief Medical Officer
|
SaleCommon Stock | 20,000 | $15.04 | $300,760.00 |
DisclosureSEC source: 0001193125-26-095181 · ownership.xml · nonDerivative · entry 2 Morris Shannon · CIK 0001973527 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F2 · price: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.10. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 14:00 UTC |
Morris ShannonChief Medical Officer
|
Exercise / conversionCommon Stock | 20,000 | $1.70 | $34,000.00 |
DisclosureSEC source: 0001193125-26-095181 · ownership.xml · nonDerivative · entry 1 Morris Shannon · CIK 0001973527 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 09:04 UTC |
Chacko David M.CFO and CBO
|
GrantStock option (right to buy) · Derivative | 640,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030624 · ownership.xml · derivative · entry 2 Chacko David M. · CIK 0001871801 · CFO and CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 640,000 Underlying: Common Stock · 640,000 shares Expires 2036-01-29 F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 14:05 UTC |
Lim Jonathan EDirector · Chairman & CEO · 10% owner
|
GrantStock option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030626 · ownership.xml · derivative · entry 1 Lim Jonathan E · CIK 0001283290 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 14:02 UTC |
Morris ShannonChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 625,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030619 · ownership.xml · derivative · entry 1 Morris Shannon · CIK 0001973527 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,000 Underlying: Common Stock · 625,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 14:01 UTC |
Varney Michael DavidDirector
|
GrantStock option (right to buy) · Derivative | 96,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030617 · ownership.xml · derivative · entry 1 Varney Michael David · CIK 0001638647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,000 Underlying: Common Stock · 96,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 29, 2026 Filed Jan 30, 2026 14:00 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
GrantStock option (right to buy) · Derivative | 560,000 | $0.00 Strike: $10.31 | $0.00 |
DisclosureSEC source: 0001193125-26-030615 · ownership.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560,000 Underlying: Common Stock · 560,000 shares Expires 2036-01-29 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly on the 29th day of each month (or the last day of February), starting in February 2026, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:20 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
SaleCommon Stock | 120,000 | $5.59 | $670,812.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 3 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3 · price: This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $5.50 to $5.80. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 02:20 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
Exercise / conversionCommon Stock | 120,000 | $1.70 | $204,000.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 145,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 14:00 UTC |
Bristol James ArthurDirector
|
GrantStock Option (right to buy) · Derivative | 37,762 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001193125-26-001611 · ownership.xml · derivative · entry 1 Bristol James Arthur · CIK 0001715153 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,762 Underlying: Common Stock · 37,762 shares Expires 2036-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 14:00 UTC |
LIU JEAN IDirector
|
GrantStock Option (right to buy) · Derivative | 20,617 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001193125-26-001610 · ownership.xml · derivative · entry 1 LIU JEAN I · CIK 0001241357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,617 Underlying: Common Stock · 20,617 shares Expires 2036-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 14:00 UTC |
Multani Pratik SDirector
|
GrantStock Option (right to buy) · Derivative | 19,532 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001193125-26-001609 · ownership.xml · derivative · entry 1 Multani Pratik S · CIK 0001586894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,532 Underlying: Common Stock · 19,532 shares Expires 2036-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 14:00 UTC |
Start Valerie Denise HardingDirector
|
GrantStock Option (right to buy) · Derivative | 24,306 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001193125-26-001608 · ownership.xml · derivative · entry 1 Start Valerie Denise Harding · CIK 0001652037 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,306 Underlying: Common Stock · 24,306 shares Expires 2036-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 14:00 UTC |
Casdin Alexander W.Director
|
GrantStock Option (right to buy) · Derivative | 23,872 | $0.00 Strike: $3.72 | $0.00 |
DisclosureSEC source: 0001193125-26-001606 · ownership.xml · derivative · entry 1 Casdin Alexander W. · CIK 0001455228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,872 Underlying: Common Stock · 23,872 shares Expires 2036-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| December 15, 2025 Filed Jan 9, 2026 02:20 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
GrantCommon Stock | 3,902 | $1.19 | $4,660.16 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · nonDerivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,076 F1 · price: The purchase price was calculated in accordance with the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| December 15, 2025 Filed Jan 30, 2026 09:04 UTC |
Chacko David M.CFO and CBO
|
OtherCommon Stock | 17,793 | $1.19 | $21,250.18 |
DisclosureSEC source: 0001193125-26-030624 · ownership.xml · nonDerivative · entry 1 Chacko David M. · CIK 0001871801 · CFO and CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,980 F1 · kind: Shares purchased under the Company's 2021 Employee Stock Purchase Plan F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:28 UTC |
Varney Michael DavidDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090426 · ownership.xml · derivative · entry 1 Varney Michael David · CIK 0001638647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:27 UTC |
Hambleton JulieDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090423 · ownership.xml · derivative · entry 1 Hambleton Julie · CIK 0001578771 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:27 UTC |
LIU JEAN IDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090424 · ownership.xml · derivative · entry 1 LIU JEAN I · CIK 0001241357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:26 UTC |
Start Valerie Denise HardingDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090422 · ownership.xml · derivative · entry 1 Start Valerie Denise Harding · CIK 0001652037 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:24 UTC |
Bristol James ArthurDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090418 · ownership.xml · derivative · entry 1 Bristol James Arthur · CIK 0001715153 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:25 UTC |
Multani Pratik SDirector
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090420 · ownership.xml · derivative · entry 1 Multani Pratik S · CIK 0001586894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:23 UTC |
Casdin Alexander W.Director
|
GrantStock option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0000950170-25-090415 · ownership.xml · derivative · entry 1 Casdin Alexander W. · CIK 0001455228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2035-06-23 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 24, 2026, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
| May 23, 2025 Filed Jun 3, 2025 20:15 UTC |
Multani Pratik SDirector
|
GiftCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080941 · ownership.xml · nonDerivative · entry 2 Multani Pratik S · CIK 0001586894 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Multani Family Trust U/A DTD 08/10/2006 Disclosed balance after: 6,200 F1 · acquired: The Reporting Person transferred 6,200 shares of common stock to a family trust for no consideration, for estate planning purposes. The Reporting Person holds all voting and dispositive power with respect to the securities held by the trust and remains the beneficial owner of such securities. Read SEC document |
| May 23, 2025 Filed Jun 3, 2025 20:15 UTC |
Multani Pratik SDirector
|
GiftCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-080941 · ownership.xml · nonDerivative · entry 1 Multani Pratik S · CIK 0001586894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,666 F1 · acquired: The Reporting Person transferred 6,200 shares of common stock to a family trust for no consideration, for estate planning purposes. The Reporting Person holds all voting and dispositive power with respect to the securities held by the trust and remains the beneficial owner of such securities. Read SEC document |
| March 04, 2025 Filed Mar 6, 2026 14:00 UTC |
Morris ShannonChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001193125-26-095181 · ownership.xml · derivative · entry 3 Morris Shannon · CIK 0001973527 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 515,800 Underlying: Common Stock · 20,000 shares Expires 2034-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F3 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 14:00 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
GrantStock option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0000950170-25-021831 · ownership.xml · derivative · entry 1 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-02-12 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 13, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 09:24 UTC |
Chacko David M.CFO and CBO
|
GrantStock option (right to buy) · Derivative | 800,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-25-014197 · ownership.xml · derivative · entry 3 Chacko David M. · CIK 0001871801 · CFO and CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2035-02-02 F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 14:19 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
GrantStock option (right to buy) · Derivative | 700,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-25-014194 · ownership.xml · derivative · entry 3 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700,000 Underlying: Common Stock · 700,000 shares Expires 2035-02-02 F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 14:20 UTC |
Morris ShannonChief Medical Officer
|
GrantStock option (right to buy) · Derivative | 780,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-25-014195 · ownership.xml · derivative · entry 1 Morris Shannon · CIK 0001973527 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 780,000 Underlying: Common Stock · 780,000 shares Expires 2035-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 14:15 UTC |
Lim Jonathan EDirector · Chairman & CEO · 10% owner
|
GrantStock option (right to buy) · Derivative | 2,500,000 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0000950170-25-014192 · ownership.xml · derivative · entry 1 Lim Jonathan E · CIK 0001283290 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500,000 Underlying: Common Stock · 2,500,000 shares Expires 2035-02-02 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on February 1, 2025, subject to the Reporting Person's continuous service to the issuer on each such vesting date. Read SEC document |
| January 07, 2025 Filed Jan 9, 2026 02:20 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
Exercise / conversionStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $1.70 | $0.00 |
DisclosureSEC source: 0001193125-26-008076 · ownership.xml · derivative · entry 4 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 120,000 shares Expires 2034-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on June 30, 2024. F4 · derivative.exercise_date: The shares subject to this option award are fully vested and exercisable as of the date hereof. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 01:28 UTC |
Casdin Alexander W.Director
|
GrantStock Option (right to buy) · Derivative | 28,877 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0000950170-25-000639 · ownership.xml · derivative · entry 1 Casdin Alexander W. · CIK 0001455228 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,877 Underlying: Common Stock · 28,877 shares Expires 2035-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 01:21 UTC |
LIU JEAN IDirector
|
GrantStock Option (right to buy) · Derivative | 24,939 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0000950170-25-000637 · ownership.xml · derivative · entry 1 LIU JEAN I · CIK 0001241357 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,939 Underlying: Common Stock · 24,939 shares Expires 2035-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 01:19 UTC |
Start Valerie Denise HardingDirector
|
GrantStock Option (right to buy) · Derivative | 29,402 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0000950170-25-000635 · ownership.xml · derivative · entry 1 Start Valerie Denise Harding · CIK 0001652037 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,402 Underlying: Common Stock · 29,402 shares Expires 2035-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 01:14 UTC |
Bristol James ArthurDirector
|
GrantStock Option (right to buy) · Derivative | 45,678 | $0.00 Strike: $2.51 | $0.00 |
DisclosureSEC source: 0000950170-25-000630 · ownership.xml · derivative · entry 1 Bristol James Arthur · CIK 0001715153 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,678 Underlying: Common Stock · 45,678 shares Expires 2035-01-01 F1 · security: At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2025 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2025. F2 · derivative.exercise_date: The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date. Read SEC document |
| December 13, 2024 Filed Feb 5, 2025 09:24 UTC |
Chacko David M.CFO and CBO
|
OtherCommon Stock | 12,324 | $1.56 | $19,274.74 |
DisclosureSEC source: 0000950170-25-014197 · ownership.xml · nonDerivative · entry 2 Chacko David M. · CIK 0001871801 · CFO and CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,187 F1 · kind: Shares purchased under the Company's 2021 Employee Stock Purchase Plan F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. F3 · balance_after: Reflects all transactions reported under this report. Read SEC document |
| December 13, 2024 Filed Feb 5, 2025 14:19 UTC |
Garner EbunGeneral Counsel & Corp. Sec.
|
OtherCommon Stock | 5,731 | $1.56 | $8,963.28 |
DisclosureSEC source: 0000950170-25-014194 · ownership.xml · nonDerivative · entry 2 Garner Ebun · CIK 0001364554 · General Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,174 F1 · kind: Shares purchased under the Company's 2021 Employee Stock Purchase Plan F2 · price: The purchase price was calculated in accordance with the issuer's 2021 Employee Stock Purchase Plan. F3 · balance_after: Reflects all transactions reported under this report. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 08:45 UTC |
Chacko David M.CFO and CBO
|
GrantStock Option (right to buy) · Derivative | 278,812 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-24-005923 · doc4.xml · derivative · entry 1 Chacko David M. · CIK 0001871801 · CFO and CBO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 278,812 Underlying: Common Stock · 278,812 shares Expires 2034-06-19 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest monthly, with vesting starting on June 20, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 12:56 UTC |
Varney Michael DavidDirector
|
GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0001209191-24-005929 · doc4.xml · derivative · entry 1 Varney Michael David · CIK 0001638647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2034-06-19 F1 · derivative.exercise_date: 100% of the options to purchase shares vest on June 20, 2025, subject to the Reporting Person's continuous service to the Issuer on such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.